ArticleJournal of addiction medicine2026
Opioid Overdose Risk Perceptions and Barriers and Facilitators to Naloxone Distribution for Hospitalized Patients Who Use Stimulants: A Qualitative Study of Patients and Clinicians.
Article in Journal of addiction medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesMost stimulant-related deaths in the United States involve opioids due to intentional or unintentional fentanyl toxicity. It is critical to ensure patients who use nonprescribed stimulants have access to naloxone, and hospitalization is an opportunity to provide this lifesaving medication. We aimed to understand perceptions on opioid overdose risk as well as barriers to and facilitators of take-home naloxone distribution through the perspectives of hospitalized patients who use stimulants and the clinicians who care for them.
methodsWe conducted key-informant interviews with hospitalized patients who use cocaine or methamphetamine and hospital-based, nonaddiction medicine specialized nurses, physicians, and advanced practice providers. We analyzed results using a rapid matrix-based qualitative technique.
resultsThirteen patients and 13 clinicians participated. Themes included: (1) people who use stimulants have personal, traumatic experiences with opioid overdose, even if they do not intentionally use opioids (patients); (2) despite awareness of stimulant adulteration with fentanyl, patients and hospital-based clinicians differ in their perceptions of opioid overdose risk (patients and clinicians); and (3) factors impacting in-hospital naloxone distribution include competing work-related priorities, logistical considerations necessary to ensure patients receive naloxone in-hand before discharge, and the cost of naloxone (clinicians).
conclusionsStrategies to increase take-home naloxone receipt among hospitalized patients must consider the specific needs of patients who use stimulants, who may view themselves as low-risk for opioid overdose but be open to carrying naloxone for the benefit of others. Clinicians suggested strategies to address logistical considerations of naloxone delivery unique to the hospital environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.